ASPG
60 kDa lysophospholipase
Also known as: C14orf76, hASNase1, LPP60_HUMAN, LysoLP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86U10
- Gene
- ASPG
- Ensembl
- ENSG00000166183
- Chromosome
- 14
- Canonical length
- 573 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable acyltransferase activity, transferring groups other than amino-acyl groups; asparaginase activity; and lysophospholipase activity. Predicted to be involved in asparagine metabolic process and phospholipid metabolic process. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
573 residues, UniProt reviewed canonical sequence.
>Q86U10|ASPG
1 MARAVGPERR LLAVYTGGTI GMRSELGVLV PGTGLAAILR TLPMFHDEEH ARARGLSEDT
61 LVLPPASRNQ RILYTVLECQ PLFDSSDMTI AEWVCLAQTI KRHYEQYHGF VVIHGTDTMA
121 FAASMLSFML ENLQKTVILT GAQVPIHALW SDGRENLLGA LLMAGQYVIP EVCLFFQNQL
181 FRGNRATKVD ARRFAAFCSP NLLPLATVGA DITINRELVR KVDGKAGLVV HSSMEQDVGL
241 LRLYPGIPAA LVRAFLQPPL KGVVMETFGS GNGPTKPDLL QELRVATERG LVIVNCTHCL
301 QGAVTTDYAA GMAMAGAGVI SGFDMTSEAA LAKLSYVLGQ PGLSLDVRKE LLTKDLRGEM
361 TPPSVEERRP SLQGNTLGGG VSWLLSLSGS QEADALRNAL VPSLACAAAH AGDVEALQAL
421 VELGSDLGLV DFNGQTPLHA AARGGHTEAV TMLLQRGVDV NTRDTDGFSP LLLAVRGRHP
481 GVIGLLREAG ASLSTQELEE AGTELCRLAY RADLEGLQVW WQAGADLGQP GYDGHSALHV
541 AEAAGNLAVV AFLQSLEGAV GAQAPCPEVL PGVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASPG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 143 nTPM
Expression across tissuesHPA
Tissue
- liver: 143 nTPM
- heart muscle: 98 nTPM
- esophagus: 34 nTPM
- kidney: 12 nTPM
- ovary: 11 nTPM
- skin: 9.7 nTPM
Single-cell type
- esophageal apical cells: 1,153 nCPM
- esophageal suprabasal cells: 199 nCPM
- hepatocytes: 108 nCPM
- epididymal principal cells: 67 nCPM
- suprabasal keratinocytes: 40 nCPM
- ocular epithelial cells: 27 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 2.7 nTPM
- midbrain: 1.8 nTPM
- medulla oblongata: 1.4 nTPM
- hippocampal formation: 1 nTPM
- thalamus: 1 nTPM
- basal ganglia: 0.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.95
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- L-amino acid metabolic process
- lipid catabolic process
- aspartate family amino acid metabolic process
Molecular functions
- 1-alkyl-2-acetylglycerophosphocholine esterase activity
- acyltransferase activity, transferring groups other than amino-acyl groups
- asparaginase activity
- phosphatidylcholine lysophospholipase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ankyrin repeat
- Ankyrin repeat-containing domain superfamily
- Ankyrin repeats (3 copies)
- Type I L-asparaginase family
- Asparaginase/glutaminase-like
- L-asparaginase, C-terminal
- L-asparaginase, N-terminal
- Asparaginase/glutaminase, active site 2
- Asparaginase/glutaminase-like superfamily
- L-asparaginase, N-terminal domain superfamily
- Asparaginase/glutaminase, C-terminal
- Type I (cytosolic) L-asparaginase
- Asparaginase, N-terminal
- Glutaminase/Asparaginase C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASPG as an antibody target. Whether an autoantibody or antibody against ASPG could matter depends on whether native ASPG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASPG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASPG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...